Report of Foreign Issuer (6-k)
August 22 2016 - 8:31AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
Report
of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16
Under the Securities Exchange Act of 1934
For
the Month of August 2016
000-13248
(Commission File Number)
VBI
VACCINES INC.
(Exact
name of Registrant as specified in its charter)
222
Third Street, Suite 2241
Cambridge,
Massachusetts 02142
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover
Form 20-F or Form 40-F.
Form 20-F [X] Form 40-F [ ]
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(1): ____
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(7): ____
Exhibit
Index
|
Exhibit
No.
|
|
Description
|
|
|
|
|
|
99.1
|
|
News
Release dated August 22, 2016.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
VBI
Vaccines Inc.
|
|
|
|
|
Date:
August 22, 2016
|
By:
|
/s/
Jeff Baxter
|
|
|
|
Jeff
Baxter
|
|
|
|
President
and Chief Executive Officer
|
VBI Vaccines (NASDAQ:VBIV)
Historical Stock Chart
From Mar 2024 to Apr 2024
VBI Vaccines (NASDAQ:VBIV)
Historical Stock Chart
From Apr 2023 to Apr 2024
